Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?

17 Nov 2023

Abstract excerpt

Huntington's disease is classically looked upon solely as a genetic neurodegenerative disease. However, the disease is a whole-body disorder and presents not only with neuronal pathology, but with wide-spread pathological alterations.1,2 The increased CAG repeat number in the gene coding for the protein huntingtin is expressed throughout the body and peripheral pathology has been suggested to parallel central...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37979315
DOI: 10.1016/j.ebiom.2023.104882

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?PMID 37979315Read ↗

Targeting energy metabolism in Huntington's disease.Semantic proximity Read ↗

Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure?Semantic proximity Read ↗

Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.Semantic proximity Read ↗

Energy deficit in Huntington disease: why it mattersSemantic proximity Read ↗

Huntington’s Disease and Diabetes: Chronological Sequence of its AssociationSemantic proximity Read ↗

Energy dysfunction in Huntington’s disease: insights from PGC-1α, AMPK, and CKBSemantic proximity Read ↗

One Molecule for Mental Nourishment and More: Glucose Transporter Type 1—Biology and Deficiency SyndromeSemantic proximity Read ↗

The metabolic profile of early Huntington's disease- a combined human and transgenic mouse studySemantic proximity Read ↗

Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits.Semantic proximity Read ↗

GLUT1 deficiency and other glucose transporter diseases.Semantic proximity Read ↗

Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.Semantic proximity Read ↗

Therapeutic strategies for glucose transporter 1 deficiency syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.